Piezo1-ADAM axis promotes inflammatory alveolar-capillary crosstalk resulting in transendothelial leukocyte migration
This study reveals that mechanical stress-induced activation of the Piezo1 ion channel in lung epithelial cells triggers the release of ADAM protease-dependent inflammatory factors, which subsequently activate endothelial cells to promote leukocyte transmigration across the alveolar-capillary barrier.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The lungs are a marvel of engineering, constantly expanding and contracting with every breath we take. This rhythmic motion is essential for life, but it also subjects the delicate tissues inside our chest to relentless physical pressure. Under normal conditions, the cells lining the air sacs and the blood vessels work together seamlessly to maintain a stable environment, filtering oxygen into the blood while keeping harmful substances out. However, when this mechanical stress becomes too intense or prolonged, such as during severe illness or aggressive medical ventilation, the system can break down. The barrier between the air and the blood becomes leaky, allowing immune cells to flood into the lung tissue and cause damaging inflammation. For years, scientists have known that mechanical forces trigger these inflammatory responses, but the specific molecular chain of events that translates a physical squeeze into a chemical alarm has remained a mystery.
A new study from researchers at the University Hospital RWTH Aachen in Germany has finally begun to map out this hidden pathway. They discovered that a specific sensor on the surface of lung cells acts as the starting gun for this inflammatory cascade. When these cells are stretched or squeezed, a channel protein called Piezo1 opens up, allowing calcium to rush inside. This influx of calcium does not just stay within the cell; it triggers a chain reaction that reaches out to neighboring blood vessel cells, telling them to open their gates to immune cells. The researchers found that this communication relies on a pair of molecular scissors, known as ADAM enzymes, which cut and release signaling molecules from the surface of the lung cells. These released molecules then travel to the blood vessel cells, activating them and preparing them to let white blood cells pass through. Without this specific cutting mechanism, the signal stops, and the inflammation does not spread.
To uncover this process, the team used a clever, step-by-step approach that allowed them to isolate each part of the conversation between the lung lining and the blood vessels. Instead of trying to observe the entire complex system at once, they first focused on the lung cells alone. They treated these cells with a substance called Yoda1, which acts like a remote control to switch on the Piezo1 sensor without actually stretching the cells physically. Once the sensor was activated, they collected the fluid surrounding the cells, which contained all the chemical messages the cells had released. They then took this fluid and applied it to human blood vessel cells grown in a separate dish. By observing how the blood vessel cells reacted to this fluid, the researchers could see exactly what the lung cells were saying and how the blood vessels responded.
The results showed that when the Piezo1 sensor was turned on, the lung cells released a wide array of inflammatory signals. However, when the researchers blocked the activity of the ADAM enzymes, the lung cells stopped releasing many of these critical signals. This proved that the ADAM enzymes are essential for the lung cells to send their message. The fluid from the treated lung cells caused the blood vessel cells to turn on specific genes associated with inflammation and to produce proteins that act like sticky hooks for immune cells. When the researchers blocked the ADAM enzymes in the lung cells before collecting the fluid, the blood vessel cells remained calm and did not activate these genes. This confirmed that the ADAM enzymes are the bridge that connects the mechanical stress on the lung cells to the chemical activation of the blood vessels.
The study went further to see if this chemical conversation actually changed the behavior of the immune system. The researchers set up a system where they placed human white blood cells on top of a layer of blood vessel cells. They then added the fluid from the Piezo1-activated lung cells to the bottom of the chamber. In this setup, the white blood cells moved through the blood vessel layer, mimicking what happens during lung injury. When the researchers blocked the ADAM enzymes in the lung cells, the white blood cells stopped moving through the barrier. This demonstrated that the entire process—from the initial mechanical stress to the final invasion of immune cells—depends on the lung cells using ADAM enzymes to cut and release their signals.
Interestingly, the researchers found that the blood vessel cells did not just passively receive these signals; they also started producing their own inflammatory chemicals, creating a feedback loop that could amplify the damage. The study identified several key pathways inside the blood vessel cells that were responsible for this reaction, including specific signaling routes involving proteins like STAT3 and NFκB. While blocking one of these routes reduced the movement of immune cells, it did not stop it completely, suggesting that the system is robust and uses multiple overlapping signals to ensure the immune response happens. The only way to fully stop the process was to prevent the lung cells from releasing their signals in the first place by blocking the ADAM enzymes.
This discovery provides a clear molecular explanation for how physical stress in the lungs can lead to severe inflammation. It shows that the lung cells do not just suffer from the stress; they actively translate it into a chemical language that recruits the immune system. The researchers suggest that targeting the ADAM enzymes or the Piezo1 sensor could offer a new way to treat lung injuries caused by mechanical stress, such as those seen in patients on ventilators or those suffering from acute respiratory distress. By stopping the initial signal at the source, it might be possible to prevent the immune system from causing further damage to the delicate lung tissue. The work highlights how a simple physical force can be converted into a complex biological response, revealing a new target for protecting the lungs when they are under the most pressure.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.